Search Results for Leukemia -- Genetic aspects.SirsiDynix Enterprisehttps://catalog.iyte.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dLeukemia$002b--$002bGenetic$002baspects.$0026rm$003dTEZ$002bKOLEKSIYONU0$00257C$00257C$00257C1$00257C$00257C$00257C0$00257C$00257C$00257Ctrue$0026te$003dILS$0026ps$003d300?2024-07-27T00:36:26ZDetermination of therapeutic potential of luteolin for acute lymphoblastic leukemia cellsent://SD_ILS/0/SD_ILS:21409452024-07-27T00:36:26Z2024-07-27T00:36:26Zby Gürler, Sevim Beyza, author.<br/><a href="https://hdl.handle.net/11147/10913">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cellsent://SD_ILS/0/SD_ILS:4789552024-07-27T00:36:26Z2024-07-27T00:36:26Zby Adan Gökbulut, Aysun, author.<br/><a href="http://hdl.handle.net/11147/4275">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cellsent://SD_ILS/0/SD_ILS:21406282024-07-27T00:36:26Z2024-07-27T00:36:26Zby Uzuner, Erez, author.<br/><a href="https://hdl.handle.net/11147/10917">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Sensitization of philadelphia positive acute lymphoblastic leukemia cells resistant to imatinib by targeting sphingolipid metabolisment://SD_ILS/0/SD_ILS:21409602024-07-27T00:36:26Z2024-07-27T00:36:26Zby Kiraz, Yağmur, author.<br/><a href="https://hdl.handle.net/11147/10912">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>